DE69228727D1 - Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten - Google Patents

Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten

Info

Publication number
DE69228727D1
DE69228727D1 DE69228727T DE69228727T DE69228727D1 DE 69228727 D1 DE69228727 D1 DE 69228727D1 DE 69228727 T DE69228727 T DE 69228727T DE 69228727 T DE69228727 T DE 69228727T DE 69228727 D1 DE69228727 D1 DE 69228727D1
Authority
DE
Germany
Prior art keywords
certain
biphenyltetrazole
derivatives
preparation
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228727T
Other languages
English (en)
Other versions
DE69228727T2 (de
Inventor
William V Murray
Ronald Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of DE69228727D1 publication Critical patent/DE69228727D1/de
Publication of DE69228727T2 publication Critical patent/DE69228727T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69228727T 1991-11-01 1992-10-30 Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten Expired - Fee Related DE69228727T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/786,666 US5252753A (en) 1991-11-01 1991-11-01 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Publications (2)

Publication Number Publication Date
DE69228727D1 true DE69228727D1 (de) 1999-04-29
DE69228727T2 DE69228727T2 (de) 1999-08-19

Family

ID=25139265

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228727T Expired - Fee Related DE69228727T2 (de) 1991-11-01 1992-10-30 Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten

Country Status (11)

Country Link
US (1) US5252753A (de)
EP (1) EP0540356B1 (de)
JP (1) JP3145813B2 (de)
AT (1) ATE178058T1 (de)
AU (1) AU651014B2 (de)
CA (1) CA2081847A1 (de)
DE (1) DE69228727T2 (de)
DK (1) DK0540356T3 (de)
ES (1) ES2130161T3 (de)
GR (1) GR3030330T3 (de)
SG (1) SG47012A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
AU3868595A (en) * 1994-10-27 1996-05-23 Novartis Ag Process for the preparation of tetrazoles
FR2753705B1 (fr) * 1996-09-20 1999-08-06 Procede pour la preparation de derives de 4-methyl-biphenyle
WO2002083127A1 (fr) * 2001-04-09 2002-10-24 Tokai University Educational System Compositions inhibant la modification proteique
EP1571150A1 (de) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Prozess zur Herstellung von Tryptase Hemmstoffen
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
CA2575177A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Purification of olmesartan medoxomil
EP1706401A1 (de) * 2004-09-02 2006-10-04 Teva Pharmaceutical Industries Ltd. Herstellung von olmesartan-medoxomil
EP1749828A1 (de) 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012037298A1 (en) * 2010-09-17 2012-03-22 Glaxosmithkline Llc Fatty acid synthase inhibitors
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69024556T2 (de) * 1989-07-28 1996-10-17 Merck & Co Inc Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten
DE122007000050I1 (de) * 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
US5039814A (en) * 1990-05-02 1991-08-13 Merck & Co., Inc. Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl)benzenes
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process

Also Published As

Publication number Publication date
DE69228727T2 (de) 1999-08-19
AU651014B2 (en) 1994-07-07
JPH05279350A (ja) 1993-10-26
AU2740492A (en) 1993-05-06
EP0540356A3 (en) 1993-08-25
ES2130161T3 (es) 1999-07-01
JP3145813B2 (ja) 2001-03-12
US5252753A (en) 1993-10-12
GR3030330T3 (en) 1999-09-30
DK0540356T3 (da) 1999-10-11
EP0540356A2 (de) 1993-05-05
EP0540356B1 (de) 1999-03-24
CA2081847A1 (en) 1993-05-02
ATE178058T1 (de) 1999-04-15
SG47012A1 (en) 1998-03-20

Similar Documents

Publication Publication Date Title
DE69228727D1 (de) Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten
DE69210347T2 (de) Verfahren zur Herstellung von Zwischenprodukten zur Verwendung in der Herstellung von Alkoxyiminoacetamide
DE69528762D1 (de) Herstellung von camptothecinderivaten durch intramolekulare cyclisierung
ATE207884T1 (de) Verfahren zur herstellung von aminobenzol- derivaten
DE69222012D1 (de) Verfahren zur Herstellung von Alpha-Ketoamidderivaten
DE3885115T2 (de) Verfahren zur Herstellung von Thiolen.
DE69521012T2 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
DE69632919D1 (de) Verfahren zur herstellung von 2-chlor-5-chloromethyl-thiazol
ATE272061T1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
DE69127960T2 (de) Verfahren zur Herstellung von (S)-vinyl- und (S)-allenyl-Gaba
DE3786770T2 (de) Stereokonvergentverfahren zur Herstellung von optisch aktiven Carbonsäuren.
JPS5634684A (en) Novel oxoopyrido*1*22a*thienopyrimidine compound and its manufacture
NO924113L (no) Fremgangsmaate for fremstilling av substituerte indoler
DE69130995D1 (de) Verfahren zur Herstellung von 5-Arylhydantoin
ATE127784T1 (de) Verfahren und zwischenprodukte für die herstellung von 2-hydroxy-3-sulfido-3- phenylpropansäuren.
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
IT1180645B (it) Intermedi per la sintesi di acidi carbossilici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee